Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 01, 2025, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Pantoprazole Sodium for Injection, 40 mg/vial (Single-Dose Vial)".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 01, 2025, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Pantoprazole Sodium for Injection, 40 mg/vial (Single-Dose Vial)".